The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic Drug
Calum Marr(Queen's University Belfast), Bernadette McGuinness(Queen's University Belfast), Chris R. Cardwell(Queen's University Belfast), Clive Holmes(University of Eastern Finland), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Bethany McDowell(Queen's University Belfast), G Meenagh(Northern Health and Social Care Trust), Michelle McHenry(Belfast Health and Social Care Trust), Jessica L. Teeling(University of Southampton)
Cited by 3
Related Papers
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
|Nature Genetics|2009|3.4k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
|Nature Genetics|2011|2.1k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k